New directions for the treatment of tendinopathies

Authors

  • Theodore J.R. Lownie MSc in Applied Science, Saint Mary's University, Halifax, NS
  • Austin Y. MacDonald MSc in Applied Science, Saint Mary's University, Halifax, NS

DOI:

https://doi.org/10.15273/dmj.Vol50No1.12494

Abstract

Tendinopathies are among the leading causes of Nova Scotia's high rate of disability and the incidence of tendinopathy is increasing in developed nations with aging populations. The considerable impact of tendinopathies may stem from a shortfall of effective treatments. Presently, even the most successful medical interventions cannot fully restore the properties of damaged tendons. This gap signals a need for novel treatments with the potential to improve tissue regeneration. Increased research into treatments involving (i) transcutaneous nitric oxide, (ii) sclerotherapy, (iii) extracorporeal shock wave therapy, (iv) the administration of growth factors, (v) stem cell therapy, and (vi) biomaterials could help reduce individual suffering, strengthen Nova Scotia's workforce, and decrease the portion of the population relying on limited provincial disability payouts and stipends for disabled persons.

Downloads

Published

2025-07-28

How to Cite

Lownie, T., & MacDonald, A. (2025). New directions for the treatment of tendinopathies. DALHOUSIE MEDICAL JOURNAL, 50(1), 3–7. https://doi.org/10.15273/dmj.Vol50No1.12494

Issue

Section

Review